Chlorothiazide
- Generic Name
- Chlorothiazide
- Brand Names
- Diuril
- Drug Type
- Small Molecule
- Chemical Formula
- C7H6ClN3O4S2
- CAS Number
- 58-94-6
- Unique Ingredient Identifier
- 77W477J15H
- Background
A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. (From Martindale, The Extra Pharmacopoeia, 30th ed, p812)
- Indication
Chlorothiazide is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. It is also indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.
- Associated Conditions
- Edema, Hypertension
- Associated Therapies
- -
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 60
- Registration Number
- NCT02606253
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Treatment of Hypertension
Phase 3
Completed
- Conditions
Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Completed
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Registration Number
- NCT00004360
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath